Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors

CONCLUSIONS: This pharmacokinetic pilot study indicated penetration of bevacizumab into the CSF in a population of children, adolescents, and young adults with recurrent brain tumors.PMID:38587585 | DOI:10.1007/s40272-024-00624-y
Source: Paediatric Drugs - Category: Pediatrics Authors: Source Type: research